Organization: Health Canada
Year: 2024
Month: March
Request Number: A-2023-000639
Request Summary: With respect to generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-06-22 for the medicinal ingredient mesalazine, any document that would indicate the current status of the submission.
Disposition: Disclosed in part
Number of pages: 1